Abstract
AbstractDuring 2022, the COVID-19 pandemic has been dominated by the variant of concern (VoC) Omicron (B.1.1.529) and its rapidly emerging subvariants, including Omicron-BA.1 and -BA.2. Rapid antigen tests (RATs) are part of national testing strategies to identify SARS-CoV-2 infections on site in a community setting or to support layman’s diagnostics at home. We and others have recently demonstrated an impaired RAT detection of infections caused by Omicron-BA.1 compared to Delta. Here, we evaluated the performance of five SARS-CoV-2 RATs in a single-centre laboratory study examining a total of 140 SARS-CoV-2 PCR-positive respiratory swab samples, 70 Omicron-BA.1 and 70 Omicron-BA.2, as well as 52 SARS-CoV-2 PCR-negative swabs collected from March 8th until April 10th, 2022. One test did not meet minimal criteria for specificity. In an assessment of the analytical sensitivity in clinical specimen, the 50% limit of detection (LoD50) ranged from 4.2 × 104 to 9.2 × 105 RNA copies subjected to the RAT for Omicron-BA.1 compared to 1.3 × 105 to 1.5 × 106 for Omicron-BA.2. Overall, intra-assay differences for the detection of Omicron-BA.1-containing and Omicron-BA.2-containing samples were non-significant, while a marked overall heterogeneity among the five RATs was observed. To score positive in these point-of-care tests, up to 22-fold (LoD50) or 68-fold (LoD95) higher viral loads were required for the worst performing compared to the best performing RAT. The rates of true-positive test results for these Omicron subvariant-containing samples in the highest viral load category (Ct values < 25) ranged between 44.7 and 91.1%, while they dropped to 8.7 to 22.7% for samples with intermediate Ct values (25–30). In light of recent reports on the emergence of two novel Omicron-BA.2 subvariants, Omicron-BA.2.75 and BJ.1, awareness must be increased for the overall reduced detection rate and marked differences in RAT performance for these Omicron subvariants.
Funder
Free State of Bavaria
Ludwig-Maximilians-Universität München
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Immunology,General Medicine,Immunology and Allergy
Reference57 articles.
1. Du Z, Tian L, Jin DY (2022) Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect. 11(1):1394–1401. https://doi.org/10.1080/22221751.2022.2076616 (Epub 2022/05/11)
2. World Health Organization (2022) Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Ag-RDTs-Self_testing-2022.12022. [Accessed 10 July 2022].
3. Greub G, Caruana G, Schweitzer M, Imperiali M, Muigg V, Risch M et al (2021) Multicenter technical validation of 30 rapid antigen tests for the detection of SARS-CoV-2 (VALIDATE). Microorganisms 9(12):2589. https://doi.org/10.3390/microorganisms9122589 (Epub 2021/12/25)
4. Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C et al (2021) Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. https://doi.org/10.2807/1560-7917.Es.2021.26.44.2100441 (Epub 2021/11/0)
5. Kim J, Sung H, Lee H, Kim JS, Shin S, Jeong S et al (2022) Clinical performance of rapid and point-of-care antigen tests for SARS-CoV-2 variants of concern: a living systematic review and meta-analysis. Viruses 14(7):1479. https://doi.org/10.3390/v14071479 (Epub 2022/07/28)
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献